Description
Generic Version of Trastuzumab Available in India?
Trastuzumab is the generic name of the medication and is its international nonproprietary name. Trastuzumab is marketed under the brand name Canmab among others. Trastuzumab injection is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer. It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).
The new indications are:
HER2-Low Metastatic Breast Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with unresectable or metastatic HER2-Low breast cancer who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy.
Locally Advanced or Metastatic Gastric Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab based regimen.
Trastuzumab deruxtecan was earlier approved by Drug Controller General of India (DCGI), for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen.
Approved in May 2023 for the treatment of metastatic breast cancer. In March 2024, the Central Drugs Standard Control Organisation (CDSCO) approved the drug for two additional indications: HER2-low metastatic breast cancer and HER2-positive gastric cancer.
Will this product be accessible across all regions of India?
The product – Canmab (Trastuzumab) Injection will be available across India on request. Trastuzumab is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
List of available brand-name drugs in India for Trastuzumab Injection
Branded Generic Drugs for Trastuzumab Injection: Biceltis | Canmab | Eleftha | Herclon | Hermab | Hersima Hertraz | Hervycta | Trasturel | Trazumab | Trumab | Ujvira
NEWS / UPDATES
- Aurobindo Pharma secures marketing authorisation for Trastuzumab biosimilar in India.
- AstraZeneca India receives CDSCO approval for sale, distribution of Trastuzumab.
- Trastuzumab Biosimilar, Hervycta, Launches in India.
- India’s first US FDA approved Biosimilar Trastuzumab brings new hope to patients.
- Generic Herceptin Approved in India.
- Roche-Launches-2-In-1-Biotech-Drug-For-Breast-Cancer-In-India.
- Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India.
- Roche Pharma launches PHESGO in India for the treatment of HER-2 positive breast .
